"The team is on a mission to contribute to the future of vaccine administration and (re-) distribution; a mission closely aligned with our impact investing goals," says Jelena Jakulj, Partner at Shaping Impact Group.
"This investment is a crucial milestone for uPATCH as we continue our mission to make drugs and vaccines accessible to everyone on earth," says Paul Bromberg, CEO of uPATCH.
"Shaping Impact Group's vision for supporting impactful innovation aligns perfectly with our goals, and their backing will accelerate our efforts to unlock the potential of microneedles," Paul Bromberg explains.
"Microneedles are a new drug delivery method recognized by the World Health Organization for their benefits over traditional needles. They are painless, require less medication..."
Collection
[
|
...
]